Clinical Trial: A Study to Identify and Characterize LAL-D Patients in High-risk Populations

Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational

Official Title: A Study to Identify the Frequency of Lysosomal Acid Lipase Deficiency in At-Risk Patient Populations

Brief Summary: The objective of this study is to determine the frequency of Lysosomal Acid Lipase Deficiency (LAL D) by lysosomal acid lipase (LAL) enzyme activity assay in patients who are considered to be at risk.

Detailed Summary:
Sponsor: Alexion Pharmaceuticals

Current Primary Outcome: LAL D frequency based on LAL enzyme assay. [ Time Frame: approximately 1 month ]

The endpoint of this study is the frequency of LAL D in at-risk patients, based on results from the LAL enzyme assay.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Alexion Pharmaceuticals

Dates:
Date Received: January 19, 2015
Date Started: December 2014
Date Completion:
Last Updated: May 23, 2016
Last Verified: May 2016